Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor–Positive, HER2-Negative Advanced Breast CancerVered Stearns, Anil A. Joy, Dongrui R. Lu et al.|Clinical Breast Cancer|2018Cited by 22
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR+/HER2− Advanced Breast Cancer Enrolled in an Expanded Access ProgramAdam Brufsky, Vered Stearns, Debanjali Mitra et al.|Clinical Breast Cancer|2019Cited by 20